Clinics Face Pressure on Refills, Nutrition Sales, and Workload

Merck Animal Health announced on March 18, 2026 that the U.S. Food and Drug Administration approved an expanded label for BRAVECTO QUANTUM in dogs. The updated label adds treatment and control of Asian longhorned tick and Gulf Coast tick for 12 months after a single injection administered by a veterinarian. Merck’s current product page reflects those tick species on the label. ^{1  2}

dvm360 separately reported the same FDA label expansion. ³

A once-yearly injectable strengthens clinic control of parasite prevention. Fewer refill points reduce the chances that a patient shifts to retail, online pharmacy, or drops off treatment. Operators should review protocol design and recommendation pathways now, as this changes how adherence and retention are managed.

High — supported by a dated Merck Animal Health release, a live Merck product page showing the updated tick coverage, and secondary corroboration from dvm360. The main uncertainty is how quickly clinics adopt the expanded label into protocols.

Companion Animal Parasite Council (CAPC) released its 2026 Pet Parasite Forecast on March 23, 2026 and said Lyme disease, ehrlichiosis, anaplasmosis, and heartworm risk are expanding across the United States, including in areas previously seen as lower or moderate risk. CAPC said the forecast draws on large diagnostic datasets and described the pattern as a “new era of year-round risk.” ⁴

The commercial effect is a stronger reliance on protocol control and refill retention. A clinic may lose value even when its product recommendation is sound if the patient falls off annual prevention and testing cadence or shifts the refill to an outside.

High — supported by a direct CAPC release with clear timing, national scope, and explicit statements about expanding risk and year-round prevention. The main uncertainty is how evenly clinics and clients respond by market.

Today’s Veterinary Business reported on March 23, 2026 that Freshpet agreed to alter marketing language after a National Advertising Division (NAD) review tied to “human-grade” implications in video advertisements. Better Business Bureau National Programs said on March 17, 2026 that NAD recommended discontinuing claims suggesting Freshpet dog food is “human grade.” ^{5 6}

The commercial effect is higher pressure on claims substantiation and approval workflows. The risk sits in how quickly high-premium claims move from draft to approved use across packaging, product-detail pages, paid media, and retail listings. Operators should review approval timelines and escalation paths before the next campaign cycle.

High — supported by a dated trade report and a primary decision summary from BBB National Programs. The evidence is strong. The main uncertainty is how broadly competitors and retailers tighten their own review standards.

The Farmer’s Dog announced on March 24, 2026 that it will launch for the first time at retail with Walmart. The release said its personalized meal-plan service will be available through Walmart.com beginning in April and described the move as an expansion of access across the United States. ⁷

The signal points to a hybrid distribution model. A digitally native brand is adding mass retail to widen reach while keeping a premium position. The near-term pressure sits in balancing reach, retention, and channel conflict. Operators should review channel architecture and acquisition economics before the next planning cycle.

High — supported by a direct company release with a clear launch statement, timing, and channel mechanism. The main uncertainty is how quickly the move changes share or pricing behavior across adjacent brands.

Today’s Veterinary Business reported on March 19, 2026 that the 2026 Economic State of the Veterinary Profession showed a strong veterinary job market, higher student debt, and a continued shift toward corporate ownership from 2013 to 2023. The report also said online scheduling, telehealth services, and artificial intelligence (AI) tools are used less often than core systems such as practice management software and electronic medical records. ⁸

AVMA separately said on March 11, 2026 that the 2026 report had been updated and released. ⁹

Scale still holds advantages in recruiting, financing, and multi-site execution. Technology adoption is advancing more unevenly than vendor messaging often suggests. Operators should review recruiting pressure, workflow bottlenecks, and return on investment before expanding tools or claims.

Moderate — the evidence is credible and attributable, but detailed figures rely on a trade summary of AVMA reporting. The main uncertainty is how quickly these structural pressures change execution by segment.

Kennel Connection announced on March 24, 2026 that it had fully integrated with iDogCam. Business Wire said the integration gives pet parents live camera access through the client portal and creates new revenue opportunities for pet-care facilities. ¹⁰

This may indicate a wider move to package reassurance and visibility features as paid service add-ons in pet-care software. The current evidence supports the integration itself. It does not yet show that veterinary operators will adopt similar features at scale or that these features will change retention, pricing, or workflow expectations

Low — supported by a real, attributable company announcement, but corroboration is limited and the broader pattern is still forming. The main uncertainty is whether this remains an adjacent feature or becomes a wider client expectation.

• Additional platforms launch similar features within 90 days.
• Operators charge for visibility or reassurance features.
• Clinics report measurable impact on client use or retention.

• No similar launches appear this quarter.
• The feature remains limited to boarding and daycare.
• No evidence shows change in client behavior or paid uptake.